14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today LIFE ranks #14156 as hold candidate. Get a Free Stock at Robinhood
Stronger Stock

aTyr Pharma Stock Forecast NASDAQ:LIFE

$8.61 (5.13%)

Volume: 158k

Closed: Dec 08, 2021

Hollow Logo Score: -0.244

aTyr Pharma Stock Forecast

$8.61 (5.13%)

Volume: 158k

Closed: Dec 08, 2021

Score Hollow Logo -0.244
Which way will LIFE go? Request
Stop-loss: $8.10 (-5.94%)
Key Stats
Beta 0.71
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 53 and the stock is currently not being overbought or oversold

On Wednesday aTyr Pharma stock price gained impressive 5.13%
(Updated on Dec 08, 2021)

Hold candidate since 2021-12-08

The aTyr Pharma stock price gained 5.13% on the last trading day (Wednesday, 8th Dec 2021), rising from $8.19 to $8.61. , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 8.23% from a day low at $8.04 to a day high of $8.70. The price has fallen in 5 of the last 10 days, but is still up by 6.82% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 18 thousand more shares were traded than the day before. In total, 158 thousand shares were bought and sold for approximately $1.36 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -11.06% during the next 3 months and, with a 90% probability hold a price between $3.64 and $10.05 at the end of this 3-month period.

Signals & Forecast

The aTyr Pharma stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $8.13 and $8.40. A breakdown below any of these levels will issue sell signals. aTyr Pharma has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, September 23, 2021, and so far it has fallen -31.01%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss

aTyr Pharma finds support from accumulated volume at $8.54 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.66 between high and low, or 8.23%. For the last week, the stock has had a daily average volatility of 5.40%.

Our recommended stop-loss: $8.10 (-5.94%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 53 days ago.)

Is aTyr Pharma stock A Buy?

aTyr Pharma holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.244

Predicted Opening Price for aTyr Pharma of Thursday, December 9, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 9, 2021 Current price
$8.45 $8.61 (Overvalued)
Hold/Accumulate Upgraded

Remember To Visit Our YouTube Channel

Analyst Ratings

On Nov 11, 2021 "HC Wainwright" gave "$18.00 - $11.00" rating for LIFE. The price target was set to $8.76+5.4%.

Volatility and Risk
Daily Average Volatility: 5.40 %
Overall Risk: Very High High Medium Low Very Low
5.40 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $9.00
Price: $8.61
Support: $8.54

LIFE Insider Trading Show all Trades



Last 100 transactions
Buy: 5 410 549 | Sell: 3 514 076 (Shares)
Date Action Amount Person Type
Nov 15, 2021 Buy 2 500 Shukla Sanjay Common Stock
Sep 20, 2021 Sell 250 000 Schimmel Paul Common Stock
Sep 20, 2021 Buy 250 000 Schimmel Paul Common Stock
Sep 20, 2021 Buy 250 000 Schimmel Paul Common Stock
May 21, 2021 Buy 2 285 Zaknoen Sara Stock Option (right to buy)
Show all Insider Trades


Last 100 transactions
Buy: 5 410 549 | Sell: 3 514 076 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 9.11 5.82 %
8.86 2.88 %
8.70 1.07 %
Current price: 8.61
Support 8.20 -4.80 %
8.04 -6.61 %
7.79 -9.54 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 10.26 19.16 %
9.15 6.27 %
9.00 4.53 %
Current price 8.61
Support 8.54 -0.81%
8.53 -0.93%
8.52 -1.05%

Click to get the best stock tips daily for free!

About aTyr Pharma

aTyr Pharma aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and clinical development of Physiocrine-based therapeutics for patients suffering from severe and rare diseases. The company develops Resolaris, which is in Phase Ib/II clinical trials for treating adult patients with facioscapulohumeral muscular dystrophy (FSHD), a rare genetic myopathy with an immune component; patients with early onset FSHD; and adult patients with limb-gir... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE